Dustin A. Dikeman

Dustin A. Dikeman

Auto-generated profile, based on publicly available information

Dustin A. Dikeman

Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2021 in Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
GPGarrett J. Patrick
Garrett J. Patrick
HLHaiyun Liu
Haiyun Liu
MAMartin P Alphonse
Martin P Alphonse
DDDustin A. Dikeman
Dustin A. Dikeman
CYChristine Youn
Christine Youn
LMLloyd S. Miller
Lloyd S. Miller
IgE induced by type 2 immune responses in atopic dermatitis is implicated in the progression of atopic dermatitis to other allergic diseases, including food allergies, allergic rhinitis, and asthma. However, the keratinocyte-derived signals that promote IgE and ensuing allergic diseases remain unclear. Herein, in a mouse model of atopic dermatitis–like skin inflammation induced by epicutaneous Staphylococcus aureus exposure, keratinocyte release of IL‑36α along with IL-4 triggered B cell IgE class-switching, plasma cell differentiation, and increased serum IgE levels—all of which were abrogated in IL-36R–deficient mice or anti-IL‑36R–blocking antibody–treated mice. Moreover, skin allergen sensitization during S. aureus epicutaneous exposure-induced IL-36 responses was required for the development of allergen-specific lung inflammation. In translating these findings, elevated IL‑36 cytokines in human atopic dermatitis skin and in IL‑36 receptor antagonist–deficiency patients coincided with increased serum IgE levels. Collectively, keratinocyte-initiated IL‑36 responses represent a key mechanism and potential therapeutic target against allergic diseases.

7 October 2021 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
ARAdvaitaa Ravipati
Advaitaa Ravipati
SNSabrina Nolan
Sabrina Nolan
MAMartin P Alphonse
Martin P Alphonse
DDDustin Dikeman
Dustin Dikeman
CYChristine Youn
Christine Youn
NANathan Archer
Nathan Archer

16 June 2023 in Science Advances
Verified
Journal Article
Open access
CYChristine Youn
Christine Youn
CPCristina Pontaza
Cristina Pontaza
YWYu Wang
Yu Wang
DDDustin A. Dikeman
Dustin A. Dikeman
DJDaniel P. Joyce
Daniel P. Joyce
NANathan Archer
Nathan Archer
Staphylococcus aureus is the leading cause of skin and soft tissue infections and is a major health burden due to the emergence of antibiotic-resistant strains. To address the unmet need of alternative treatments to antibiotics, a better understanding of the protective immune mechanisms against S. aureus skin infection is warranted. Here, we report that tumor necrosis factor (TNF) promoted protection against S. aureus in the skin, which was mediated by bone marrow–derived immune cells. Furthermore, neutrophil-intrinsic TNF receptor (TNFR) signaling directed immunity against S. aureus skin infections. Mechanistically, TNFR1 promoted neutrophil recruitment to the skin, whereas TNFR2 prevented systemic bacterial dissemination and directed neutrophil antimicrobial functions. Treatment with a TNFR2 agonist showed therapeutic efficacy against S. aureus and Pseudomonas aeruginosa skin infections, which involved increased neutrophil extracellular trap formation. Our findings revealed nonredundant roles for TNFR1 and TNFR2 in neutrophils for immunity against S. aureus and can be therapeutically targeted for protection against bacterial skin infections.

30 January 2024 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
SKSabrina N. Kline
Sabrina N. Kline
NONicholas A. Orlando
Nicholas A. Orlando
ALAlex J. Lee
Alex J. Lee
MWMeng-Jen Wu
Meng-Jen Wu
JZJing Zhang
Jing Zhang
NANathan Archer
Nathan Archer
Staphylococcus aureus skin colonization and eosinophil infiltration are associated with many inflammatory skin disorders, including atopic dermatitis, bullous pemphigoid, Netherton’s syndrome, and prurigo nodularis. However, whether there is a relationship between S. aureus and eosinophils and how this interaction influences skin inflammation is largely undefined. We show in a preclinical mouse model that S. aureus epicutaneous exposure induced eosinophil-recruiting chemokines and eosinophil infiltration into the skin. Remarkably, we found that eosinophils had a comparable contribution to the skin inflammation as T cells, in a manner dependent on eosinophil-derived IL-17A and IL-17F production. Importantly, IL-36R signaling induced CCL7-mediated eosinophil recruitment to the inflamed skin. Last, S. aureus proteases induced IL-36α expression in keratinocytes, which promoted infiltration of IL-17-producing eosinophils. Collectively, we uncovered a mechanism for S. aureus proteases to trigger eosinophil-mediated skin inflammation, which has implications in the pathogenesis of inflammatory skin diseases.

1 December 2021 in Science Translational Medicine
Verified
Journal Article
Closed access
OGOren Gordon
Oren Gordon
DLDonald E. Lee
Donald E. Lee
BLBessie Liu
Bessie Liu
BLBrooke Langevin
Brooke Langevin
AOAlvaro Ordonez
Alvaro Ordonez
SJSanjay Jain
Sanjay Jain
Current rifampin dosing achieves subtherapeutic concentrations within S. aureus –infected bone, which can be overcome with higher rifampin dosing.

11 January 2022 in JCI Insight
Verified
Journal Article
Open access
PDF file
AOAlvaro Ordonez
Alvaro Ordonez
MPMatthew F.L. Parker
Matthew F.L. Parker
RMRobert J. Miller
Robert J. Miller
DPDonika Plyku
Donika Plyku
CRCamilo A. Ruiz-Bedoya
Camilo A. Ruiz-Bedoya
SJSanjay Jain
Sanjay Jain
Tools for noninvasive detection of bacterial pathogens are needed but are not currently available for clinical use. We have previously shown that para -aminobenzoic acid (PABA) rapidly accumulates in a wide range of pathogenic bacteria, motivating the development of related PET radiotracers. In this study, 11 C-PABA PET imaging was used to accurately detect and monitor infections due to pyogenic bacteria in multiple clinically relevant animal models. 11 C-PABA PET imaging selectively detected infections in muscle, intervertebral discs, and methicillin-resistant Staphylococcus aureus –infected orthopedic implants. In what we believe to be first-in-human studies in healthy participants, 11 C-PABA was safe, well-tolerated, and had a favorable biodistribution, with low background activity in the lungs, muscles, and brain. 11 C-PABA has the potential for clinical translation to detect and localize a broad range of bacteria.